RhumbLine Advisers’s Genetic Technologies Ltd. GENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55K | Sell |
3,340
-399
| -11% | -$305 | ﹤0.01% | 3972 |
|
|
2025
Q1 | $697 | Hold |
3,739
| – | – | ﹤0.01% | 4043 |
|
|
2024
Q4 | $2.86K | Hold |
3,739
| – | – | ﹤0.01% | 4008 |
|
|
2024
Q3 | $2.8K | Hold |
3,739
| – | – | ﹤0.01% | 4042 |
|
|
2024
Q2 | $5.57K | Hold |
3,739
| – | – | ﹤0.01% | 4070 |
|
|
2024
Q1 | $10.8K | Hold |
3,739
| – | – | ﹤0.01% | 3854 |
|
|
2023
Q4 | $9.05K | Sell |
3,739
-1
| -0% | -$2 | ﹤0.01% | 3880 |
|
|
2023
Q3 | $14.4K | Hold |
3,740
| – | – | ﹤0.01% | 3824 |
|
|
2023
Q2 | $15.6K | Buy |
+3,740
| New | +$15.6K | ﹤0.01% | 3856 |
|